Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Food-effect pharmacokinetic study of CA-4948 in healthy male subjects
NL-OMON60414Phase 1Completed
- Sponsor
- Curis, Inc.
- Start
- Mar 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1 trial of emavusertib, sponsored by Curis, Inc. Primary endpoint: Primary endpoint(s). Started Mar 2024; status: completed.
02
Drugs
emavusertib
Beyond the preview
Go deeper on NL-OMON60414.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON60414.